Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System. Issue 9 (17th September 2020)
- Record Type:
- Journal Article
- Title:
- Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System. Issue 9 (17th September 2020)
- Main Title:
- Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System
- Authors:
- Röth, Sascha
Macartney, Thomas J.
Konopacka, Agnieszka
Chan, Kwok-Ho
Zhou, Houjiang
Queisser, Markus A.
Sapkota, Gopal P. - Abstract:
- Summary: K-RAS is known as the most frequently mutated oncogene. However, the development of conventional K-RAS inhibitors has been extremely challenging, with a mutation-specific inhibitor reaching clinical trials only recently. Targeted proteolysis has emerged as a new modality in drug discovery to tackle undruggable targets. Our laboratory has developed a system for targeted proteolysis using peptidic high-affinity binders, called "AdPROM." Here, we used CRISPR/Cas9 technology to knock in a GFP tag on the native K-RAS gene in A549 adenocarcinoma (A549 GFPKRAS ) cells and constructed AdPROMs containing high-affinity GFP or H/K-RAS binders. Expression of GFP-targeting AdPROM in A549 GFPKRAS led to robust proteasomal degradation of endogenous GFP-K-RAS, while expression of anti-HRAS-targeting AdPROM in different cell lines resulted in the degradation of both GFP-tagged and untagged K-RAS, and untagged H-RAS. Our findings imply that endogenous RAS proteins can be targeted for proteolysis, supporting the idea of an alternative therapeutic approach to these undruggable targets. Highlights: Generation of A549 cells with a homozygous knockin of GFP tag on the KRAS gene Proteasomal degradation of endogenous GFP-K-RAS using a VHL-GFP-nanobody fusion Proteasomal degradation of endogenous H/K-RAS using VHL-H/K-RAS-monobody fusion Abstract : By using the affinity-directed protein missile (AdPROM) system comprised of VHL and high-affinity binders of GFP and H/K-RAS, Röth et al.Summary: K-RAS is known as the most frequently mutated oncogene. However, the development of conventional K-RAS inhibitors has been extremely challenging, with a mutation-specific inhibitor reaching clinical trials only recently. Targeted proteolysis has emerged as a new modality in drug discovery to tackle undruggable targets. Our laboratory has developed a system for targeted proteolysis using peptidic high-affinity binders, called "AdPROM." Here, we used CRISPR/Cas9 technology to knock in a GFP tag on the native K-RAS gene in A549 adenocarcinoma (A549 GFPKRAS ) cells and constructed AdPROMs containing high-affinity GFP or H/K-RAS binders. Expression of GFP-targeting AdPROM in A549 GFPKRAS led to robust proteasomal degradation of endogenous GFP-K-RAS, while expression of anti-HRAS-targeting AdPROM in different cell lines resulted in the degradation of both GFP-tagged and untagged K-RAS, and untagged H-RAS. Our findings imply that endogenous RAS proteins can be targeted for proteolysis, supporting the idea of an alternative therapeutic approach to these undruggable targets. Highlights: Generation of A549 cells with a homozygous knockin of GFP tag on the KRAS gene Proteasomal degradation of endogenous GFP-K-RAS using a VHL-GFP-nanobody fusion Proteasomal degradation of endogenous H/K-RAS using VHL-H/K-RAS-monobody fusion Abstract : By using the affinity-directed protein missile (AdPROM) system comprised of VHL and high-affinity binders of GFP and H/K-RAS, Röth et al. demonstrate the targeted proteasomal degradation of GFP-K-RAS, which was knocked in using CRISPR/Cas9, and endogenous H/K-RAS. … (more)
- Is Part Of:
- Cell chemical biology. Volume 27:Issue 9(2020)
- Journal:
- Cell chemical biology
- Issue:
- Volume 27:Issue 9(2020)
- Issue Display:
- Volume 27, Issue 9 (2020)
- Year:
- 2020
- Volume:
- 27
- Issue:
- 9
- Issue Sort Value:
- 2020-0027-0009-0000
- Page Start:
- 1151
- Page End:
- 1163.e6
- Publication Date:
- 2020-09-17
- Subjects:
- nanobody -- monobody -- cancer targets -- RAS -- ubiquitin proteasome system -- targeted proteolysis -- PROTAC -- protein degradation -- oncogene -- RAS/MAPK signaling
Biochemistry -- Periodicals
572.05 - Journal URLs:
- http://www.cell.com/cell-chemical-biology/home ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.chembiol.2020.06.012 ↗
- Languages:
- English
- ISSNs:
- 2451-9456
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3097.733000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14268.xml